Skip to main content
. 2024 Jul 11;14(7):693. doi: 10.3390/brainsci14070693

Table 2.

Results of analysis between groups, before and after the intervention period. Data are expressed as numbers, means ± standard deviations and percentages. The statistically significant differences before and after the intervention period and between groups are marked with symbols (between baseline and after the 12-week rehabilitation period:  p < 0.001 and * p < 0.05; between groups: # p < 0.05).

Hybrid Exercise Group Tele-Exercise Group Cohen’s d
Baseline After 12 w % Changes within Group Baseline After 12 w % Changes within Group Baseiline After 12 w
Age years 60.0 ± 9.5 - - 58.7 ± 9.5 - - 0.13 -
Sex (Female) n 6 - - 8 - - - -
Body mass index kg/m2 30.5 ± 4.0 30.7 ± 4.0 3.4 ± 4.3 27.9 ± 4.9 28.9 ± 4.8 # 4.9 ± 3.9 0.58 0.53
Lean body mass kg 62.1 ± 6.5 62.4 ± 6.5 0.4 ± 3.2 58.7 ± 7.1 59.9 ± 7.4 1.8 ± 3.1 0.50 0.36
Body fat % 32.9 ± 9.2 30.8 ± 8.5 # −7.7 ± 12.7 32.7 ± 9.6 31.0 ± 9.0 −1.0 ± 20.1 0.02 0.03
Muscle mass kg 29.8 ± 4.5 33.5 ± 7.4 # 8.0 ± 17.6 29.7 ± 4.3 32.8 ± 13.3 7.0 ± 38.9 0.02 0.06
Visceral fat score 14.1 ± 4.3 13.6 ± 4.3 −4.0 ± 11.7 12.3 ± 4.2 * 11.2 ± 4.1 # −7.0 ± 22.2 0.42 0.57
Neck circumference cm 40.0 ± 3.5 38.1 ± 4.2 # −6.5 ± 7.0 38.2 ± 3.8 37.9 ± 3.6 −4.3 ± 3.5 0.49 0.28
Waist–hip ratio m 1.0 ± 0.1 0.9 ± 0.1 −5.3 ± 6.1 1.0 ± 0.1 0.9 ± 0.2 −5.1 ± 3.8 0.00 0.00
Δchest cm 4.0 ± 2.2 5.8 ± 2.0 # 33.1 ± 20.9 5.2 ± 1.6 5.6 ± 1.4 10.3 ± 57.8 0.62 0.12
d-ROMs U. carr. 337.7 ± 76.3 376.5 ± 102.4 8.7 ± 35.6 302.8 ± 77.0 316.3 ± 70.2 20.6 ± 39.8 0.46 0.69
PAT U. cor. 2671.9 ± 400.1 2823.0 ± 537.1 7.6 ± 27.7 2586.7 ± 414.1 2786.1 ± 365.4 12.5 ± 44.6 0.21 0.08
FEV1 % of predicted 90.7 ± 18.5 91.7 ± 19.9 6.3 ± 25.8 92.4 ± 16.5 100.2 ± 15.2 # −6.3 ± 25.8 0.10 0.48
FVC % of predicted 90.5 ± 16.6 91.9 ± 18.5 6.6 ± 26.6 93.0 ± 15.3 99.2 ± 14.3 # 6.6 ± 26.6 0.16 0.44
PEF % of predicted 106.4 ± 23.8 102.9 ± 26.0 −0.6 ± 31.5 106.8 ± 25.9 113.2 ± 25.3 0.6 ± 31.5 0.02 0.40
DLCO % of predicted 77.3 ± 13.5 80.9 ± 17.7 0.5 ± 32.3 67.7 ± 16.6 # 79.7 ± 15.2 26.0 ± 33.1 0.63 0.07
Handgrip kg 31.7 ± 10.1 33.4 ± 10.0 * 9.0 ± 7.2 32.5 ± 9.0 33.5 ± 10.1 * 9.1 ± 7.5 0.08 0.01
30 s sit-to-stand repetitions 11.4 ± 3.4 13.9 ± 2.5 19.8 ± 15.9 12.4 ± 3.0 14.7 ± 4.3 * 23.9 ± 7.7 0.31 0.22
6MWT m 440.5 ± 95.3 521.4 ± 88.0 15.5 ± 12.4 500.8 ± 114.9 555.6 ± 107.9 13.7 ± 12.8 0.57 0.35
6MWT % of predicted 84.4 ± 16.8 99.8 ± 13.1 - 87.1 ± 25.9 101.9 ± 16.5 - 0.12 0.14
Leg fatigue BS-resting score 0.5 ± 0.8 0.1 ± 0.3 * −3.2 ± 1.9 0.7 ± 0.9 0.7 ± 1.3 - 0.24 0.64
Leg fatigue BS-end 6MWT score 1.3 ± 1.2 1.0 ± 1.0 1.7 ± 0.9 1.8 ± 1.4 1.4 ± 2.2 0.6 ± 0.1 0.38 0.23
Dyspnea BS-resting score 0.3 ± 0.6 0.1 ± 0.3 * 0.2 ± 0.4 0.5 ± 0.8 0.6 ± 1.0 0.4 ± 0.6 0.28 0.68
Dyspnea BS-end 6MWT score 1.4 ± 1.6 0.5 ± 0.8 * −3.9 ± 1.1 2.0 ± 1.7 1.0 ± 1.4 * −3.5 ± 0.9 0.36 0.44
SBP resting mmHg 136.2 ± 15.9 128.0 ± 9.1 * −5.5 ± 12.6 125.4 ± 15.3 128.2 ± 13.6 −1.5 ± 14.3 0.69 0.02
SBP end-6MWT mmHg 155.8 ± 15.4 151.6 ± 12.3 −2.2 ± 11.4 151.7 ± 26.8 # 146.3 ± 19.8 # −6.4 ± 23.7 0.19 0.32
DBP resting mmHg 83.1 ± 11.4 83.8 ± 5.6 - 78.7 ± 7.9 81.0 ± 7.6 −2.5 ± 9.8 0.45 0.42
DBP end-6MWT mmHg 86.8 ± 9.1 87.1 ± 6.9 0.7 ± 12.7 85.2 ± 10.3 81.3 ± 9.2 1.9 ± 26.1 0.16 0.71
HR resting bpm 77.9 ± 16.0 76.5 ± 11.2 −2.3 ± 21.8 79.2 ± 13.6 76.8 ± 12.9 −4.6 ± 15.1 0.09 0.47
HR end-6MWT bpm 113.2 ± 19.0 110.6 ± 16.8 −6.5 ± 12.4 123.8 ± 18.4 113.5 ± 17.2 −6.0 ± 28.7 0.57 0.17

Abbreviations: 6MWT = six-minute walking test; BS = Borg Scale; DBP = diastolic blood pressure; DLCO = diffusing capacity for carbon monoxide; d-ROMs = reactive oxygen metabolites’ levels; FEV1 = forced expiratory volume in 1st sec; FVC= forced vital capacity; HR = heart rate; PAT = plasma antioxidant capacity; PEF = peak expiratory flow; SBP = systolic blood pressure; Δchest = chest circumference difference between maximal inhalation and exhalation. Cohen’s d effect size classification: d ≥ 0.00 to < 0.20 is ignored, d ≥ 0.20 to <0.50 is small, d ≥ 0.50 to < 0.80 is medium, d ≥ 0.80 to < 1.30 is large, and d ≥ 1.30 is very large.